Johnson & Johnson
Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.
Learn how new technology from Johnson & Johnson aims to be a game-changer not only for patients, but for surgeons, too.
The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
Check out this infographic breakdown of the company’s second-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
People who identify as LGBTQIA+ are almost three times more likely than their non-LGBTQIA+ counterparts to report poor mental health, but accessing treatment can prove to be challenging. For World Mental Health Day, learn more about the gaps surrounding mental health and how Johnson & Johnson is helping to empower this community.
As both a cancer survivor and caregiver, Shauna Smith knows the power of feeling supported when facing the disease. That’s why she founded Johnson & Johnson’s Cancer Focus Group—so every employee has somewhere to turn if they or someone they love is faced with a diagnosis.